Pulmonary thromboembolism in a patient with scant symptomatology due to COVID-19, treated at the Cuban hospital in Qatar

• Main Author: Alexander Sosa-Frias
• Format: Article
• Language: Spanish
• Published: Universidad de Ciencias Médicas de Las Tunas 2020-09-01
• Series: Revista Electrónica Dr. Zoilo E. Marinello Vidaurreta
• Subjects: coronavirus; covid-19; pneumonia; thromboembolism
• Online Access: http://revzoilomarinello.sld.cu/index.php/zmv/article/view/2463

Coronavirus disease (COVID-19) is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). For the follow-up of the disease chest radiography and chest computed tomography are useful and sensitive, showing the lesions of the lung parenchyma. The risk of pulmonary thromboembolism is increased in this disease, which can be diagnosed by chest CT angiography, looking for the presence or absence of a thrombus in the pulmonary arteries. This study presents the case of a 36-year-old male patient, from India, with a past medical history without comorbidity, who was admitted to the Cuban hospital in Qatar with the diagnosis of COVID-19. During the progress of the disease he was clinically quite stable, with only a slight increase in respiratory rate, a scant symptomatology, and side tip pain. Laboratory tests, including Dimeros-D, were altered, arousing the suspicion of a pulmonary thromboembolism. Chest CT angiography was performed, which confirmed the diagnosis. Anticoagulant treatment was prescribed, which improved the progress of the patient until his medical discharge.